Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension

NCT01836146 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01836146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01836146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
September 30, 2015
Enrollment
39 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, renal denervation